Mutual Funds
Nippon India Pharma Fund(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
566.94   +5.48
NAV(₹) as on 4/11/2026 		0.98%
  1D 		9.58%
  1Y 		17.78%
  3Y 		13.50%
  5Y
Nippon India Pharma Fund(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
1.83 		Launch Date:
05 Jun 2004
Exit Load:
1% on or before 1M, Nil after 1M 		AUM:
₹ 9,166.40 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
7.99 		Min. Investment:
SIP : ₹ 100.00
Lumpsum : ₹ 5,000.00
Scheme Benchmark:
NA
Fund Manager:
Sailesh Raj Bhan

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 30/9/2026 2.70 % 97.30 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
11.71 %

Divi's Laboratories Ltd.
7.10 %

Lupin Ltd.
6.17 %

Cipla Ltd.
6.01 %

Dr. Reddy's Laboratories Ltd.
5.45 %

Apollo Hospitals Enterprise Ltd.
4.89 %

Mankind Pharma Ltd.
4.38 %

Sai Life Sciences Ltd.
3.92 %

Ajanta Pharma Ltd.
3.61 %

Glaxosmithkline Pharmaceuticals Ltd.
3.11 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
73.96 %

Hospital & Healthcare Servic
18.86 %

Retailing
2.53 %

Business Support
1.40 %

Medical Equipment/Supplies/A
0.54 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2021-22 2022-23 2023-24 2024-25 2025-26
NAV (31/3/2026) 290.14 270.59 428.87 481.27 489.71
Net Assets (Rs Crores) 4,93,188.52 4,30,446.45 7,12,528.46 8,08,096.99 7,89,824.17
Scheme Returns(%)(Absolute) 14.83 -6.85 58.24 10.94 3.30
B'mark Returns(%)(Absolute) NA NA NA NA NA
Category Rank 43/75 65/76 17/90 30/102 25/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.88   +0.18  
6/2/2024 ₹ 926.55 18.56% - - 21.02%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.96   +0.17  
6/12/2024 ₹ 130.33 18.07% - - 9.81%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.74   +0.10  
27/12/2024 ₹ 405.14 18.06% - - 9.01%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.74   +0.13  
27/6/2025 ₹ 487.35 10.58% - - 5.44%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.08   +0.11  
28/11/2025 ₹ 326.54 - - - 10.76%
MDB Logo
Invesco India Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.00   +0.25  
7/9/2026 ₹ 435.52 - - - %
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.01   +0.18  
11/12/2023 ₹ 825.14 23.56% - - 20.08%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  566.94   +5.48  
5/6/2004 ₹ 9,166.4 9.58% 17.78% 13.50% 19.72%
MDB Logo
Tata India Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  32.65   +0.39  
28/12/2015 ₹ 1,511.49 5.17% 17.86% 13.51% 11.51%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  18.01   +0.23  
8/11/2021 ₹ 266.05 9.54% 18.45% - 12.50%